Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/6562
Full metadata record
DC FieldValueLanguage
dc.contributor.authorStaatz, Christine Een
dc.contributor.authorMartin, Nealen
dc.contributor.authorKong, David Pen
dc.contributor.authorHollingworth, Samantha Aen
dc.date.accessioned2024-12-11T02:54:21Z-
dc.date.available2024-12-11T02:54:21Z-
dc.date.issued2018-03-
dc.identifier.citationDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2018en
dc.identifier.urihttps://dora.health.qld.gov.au/qldresearchjspui/handle/1/6562-
dc.language.isoenen
dc.relation.ispartofDigestive Liver Diseaseen
dc.titlePatterns in use and costs of subsidising 5-aminosalicyclic acid compounds and biologic agents in the treatment of inflammatory bowel disease in Australiaen
dc.identifier.doi10.1016/j.dld.2017.12.016-
dc.identifier.pmid29311026-
dc.rights.holderMartin, Nen
dc.identifier.journaltitleDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.languageiso639-1en-
Appears in Sites:Gastroenterology and Hepatology, Princess Alexandra Hospital
Show simple item record

Page view(s)

46
checked on Jan 22, 2025

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.